Correvio Pharma Corp (CORV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CORV | FGEN | MRKR | ||
| Company | Correvio Pharma Corp | Fibrogen Inc CS | Marker Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.4160 | 8.74 | 1.4700 | ||
| High | 0.4200 | 8.98 | 1.5500 | ||
| Low | 0.4160 | 8.50 | 1.4500 | ||
| Latest | 0.4199 | 8.78 | 1.4900 | ||
| Change | +0.0034 | +0.08 | +0.0200 | ||
| % Change | +0.82% | +0.92% | +1.36% | ||
| Volume | 3,759,100 | 33,100 | 174,200 | ||
| 20-Day Average Volume | 2,613,240 | 40,835 | 293,435 | ||
| Previous Close | 0.4165 | 8.70 | 1.4700 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.4050 | 8.67 | 1.3907 | ||
| 20-Day Raw Stochastic | 86.56% | 31.86% | 83.33% | ||
| 20-Day Relative Strength | 55.70 | 47.09 | 60.50 | ||
| Weighted Alpha | -49.43 | -12.35 | -34.95 | ||
| Today's Opinion | 8% Buy | 40% Sell | 56% Buy | ||
| Previous Opinion | 8% Buy | 40% Sell | 56% Buy | ||
| Last Month's Opinion | 40% Sell | 24% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.19% since 05/18/20 | +4.15% since 12/23/25 | +10.37% since 12/23/25 | ||
| Low | 0.4149 on 05/19/20 | 8.36 on 12/26/25 | 1.3600 on 12/24/25 | ||
| High | 0.4200 on 05/26/20 | 9.19 on 12/29/25 | 1.5500 on 12/31/25 | ||
| 1-Month | |||||
| %Chg | +1.79% since 04/24/20 | -0.23% since 11/28/25 | +20.16% since 11/28/25 | ||
| Low | 0.3632 on 04/29/20 | 7.99 on 12/04/25 | 1.1500 on 12/01/25 | ||
| High | 0.4287 on 05/14/20 | 10.47 on 12/16/25 | 1.5500 on 12/31/25 | ||
| 3-Month | |||||
| %Chg | +20.56% since 02/26/20 | -28.33% since 09/30/25 | +66.93% since 09/30/25 | ||
| Low | 0.2800 on 03/13/20 | 7.99 on 12/04/25 | 0.8400 on 11/10/25 | ||
| High | 0.6010 on 02/28/20 | 12.46 on 10/01/25 | 1.5500 on 12/31/25 | ||
| 6-Month | |||||
| %Chg | -82.13% since 11/26/19 | +65.66% since 06/30/25 | -2.61% since 06/30/25 | ||
| Low | 0.2100 on 02/14/20 | 5.03 on 07/01/25 | 0.8099 on 08/28/25 | ||
| High | 2.3900 on 11/27/19 | 12.60 on 09/03/25 | 4.0700 on 07/17/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 27,794 | 35,195 | 24,509 | ||
| Shares Outstanding, K | 66,191 | 4,045 | 16,673 | ||
| Annual Sales | 32,630,000 | 29,620,000 | 6,590,000 | ||
| Annual Net Income | -35,180,000 | -47,580,000 | -10,730,000 | ||
| Last Quarter Sales | 11,330,000 | 1,080,000 | 1,230,000 | ||
| Last Quarter Net Income | -4,940,000 | 200,640,000 | -2,000,000 | ||
| 60-Month Beta | 0.08 | 0.74 | 1.35 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.61 on 11/10/25 | -0.12 on 11/13/25 | ||
| Latest Earnings Date | 06/03/20 | 03/16/26 | 03/30/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||